Clinical Trial Update: Enteral Glutamine in Critical Illness [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update indicates that phase 2 and phase 3 studies of enteral glutamine in critical illness, including sepsis, have been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Respiratory Insufficiency
• Sepsis

Drugs mentioned

• Enteral Glutamine (glutamine)

Snippet

Sponsor: Christiana Care Health Services | Conditions: Critical Illness, Sepsis | Phase 2, Phase 3 | Status: TERMINATED